DianiclineAlternative Names: SSR 591813
Latest Information Update: 27 Feb 2008
At a glance
- Originator sanofi-aventis
- Class Azepines; Heterocyclic compounds with 4 or more rings; Small molecules; Smoking cessation therapies
- Mechanism of Action Nicotinic receptor agonists
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
On Fast track
Fast track status is assigned by the US FDA so therapies with the potential to address unmet needs can move faster through development.
Highest Development Phases
- Discontinued CNS disorders; Smoking withdrawal